Press Releases

MARINA DEL REY, Calif., Oct. 31, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today issued the following letter to shareholders. The letter has been made available to all existing shareholders with the

· Third Quarter Adjusted Total Revenue - $18.9 million and $55.1 million year-to-date ·· Third Quarter Adjusted EBITDA - $7.8 million and $18.7 million year-to-date ·

NEWARK, Calif., Oct. 31, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced it has entered into a four-year debt facility with MidCap Financial (MidCap), the lead agent, and Silicon Valley Bank (SVB).The lenders under the debt facility will make available to Protagonist an aggregate principal amount up to

NEW YORK, Oct. 31, 2019 /PRNewswire/ -- L'Oréal USA today announced the recipients of the 2019 For Women in Science (FWIS) Fellowship, which annually awards five female postdoctoral scientists grants of $60,000 each to advance their research. This is the 16th year of the program, which to date has

BOSTON, Oct. 31, 2019 /PRNewswire/ -- TetraScience, developers of the industry's first cloud-based data integration platform for life sciences R&D, today announced it has secured a strategic investment from Waters Corporation (NYSE: WAT), the world's leading specialty measurement company. Waters Corporation joins a roster of leading venture investors in TetraSci

WALTHAM, Mass., Oct. 31, 2019 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced today that it will release its third quarter 2019 financial results on Thursday, November 7, after the clo

TEL AVIV, Israel, Oct. 31, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today that it will deliver the following poster presentations at the S

LAVAL, Quebec, Oct. 31, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, announced that the U.S. Patent and Trade

DENVER, Oct. 31, 2019 /PRNewswire/ -- Nephrology Care Alliance (NCA), a new entity seeking to empower physicians to succeed in a changing health care environment, announced that it has confirmed interest from over 500 nephrologists to participate in the NCA platform, covering both chronic kidney disease (CKD) and end stage renal disease (ESRD) patients. NCA is a phy

RANCHO CORDOVA, Calif., Oct. 31, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing for regenerative medicine, today announced that the company will change its name to ThermoGenesis Holdings, Inc. ("ThermoGenesis") in order to better reflect its new strategic focus on becoming a key solution provider for ce